{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:19:26Z","timestamp":1788801566681,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ajo.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T11:44:46Z","timestamp":1526730286000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Randomized, Controlled, Phase 2 Trial of Povidone-Iodine\/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis"],"prefix":"10.1016","volume":"194","author":[{"given":"Jay S.","family":"Pepose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Narvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2018.05.012_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAJ.0b013e3181637417","article-title":"Cost effectiveness of a point-of-care test for adenoviral conjunctivitis","volume":"336","author":"Udeh","year":"2008","journal-title":"Am J Med Sci"},{"issue":"16","key":"10.1016\/j.ajo.2018.05.012_bib2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2018.05.012_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","article-title":"Epidemiology of epidemic keratoconjunctivitis","volume":"9","author":"Ford","year":"1987","journal-title":"Epidemiol Rev"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.012_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/676877","article-title":"Selection of the ideal disinfectant","volume":"35","author":"Rutala","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.012_bib5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0161-6420(93)31389-8","article-title":"Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in\u00a0vitro","volume":"100","author":"Gordon","year":"1993","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2018.05.012_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2018.05.012_bib7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0161-6420(02)01176-4","article-title":"Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate","volume":"109","author":"Weijtens","year":"2002","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.012_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0886-3350(01)00863-X","article-title":"Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial","volume":"27","author":"Mohan","year":"2001","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.012_bib9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00417-005-0124-2","article-title":"Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation","volume":"244","author":"Saari","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.012_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/jcm.15.4.635-639.1982","article-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions","volume":"15","author":"Berkelman","year":"1982","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ajo.2018.05.012_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9394(14)71640-X","article-title":"Efficacy of topical povidone-iodine during the first week after ophthalmic surgery","volume":"124","author":"Isenberg","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.012_bib12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2018.05.012_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.10-5944","article-title":"Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis","volume":"52","author":"Clement","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2018.05.012_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv Ther"},{"issue":"9","key":"10.1016\/j.ajo.2018.05.012_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res"},{"issue":"8","key":"10.1016\/j.ajo.2018.05.012_bib16","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.05.012_bib17","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/bjo.2010.188623","article-title":"A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis","volume":"95","author":"Wilkins","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.012_bib18","first-page":"623","article-title":"A patient preference comparison of Azarga (brinzolamide\/timolol fixed combination) vs Cosopt (dorzolamide\/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension","volume":"2","author":"Mundorf","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.012_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","article-title":"The effects of corticosteroids of adenoviral replication","volume":"114","author":"Romanowski","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"7418","key":"10.1016\/j.ajo.2018.05.012_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.327.7418.789","article-title":"Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search","volume":"327","author":"Rietveld","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ajo.2018.05.012_bib21","first-page":"1071","article-title":"Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing","volume":"55","author":"Visscher","year":"2009","journal-title":"Can Fam Physician"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.012_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/cpr.13.50","article-title":"Antiseptics in the era of bacterial resistance: a focus on povidone iodine","volume":"10","author":"Lachapelle","year":"2013","journal-title":"Clin Pract"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.012_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0002-9394(14)74560-X","article-title":"The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine","volume":"109","author":"Benevento","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.012_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcrs.2010.11.028","article-title":"In\u00a0vitro efficacy of a povidone-iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens","volume":"37","author":"Pelletier","year":"2011","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.012_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection","volume":"131","author":"Yin","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.012_bib26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.012_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajo.2013.10.003","article-title":"Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics","volume":"157","author":"Hsu","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.05.012_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis: challenges in diagnosis and clinical management","volume":"11","author":"Azher","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2018.05.012_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246027","article-title":"Inactivation of human viruses by povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kawana","year":"1997","journal-title":"Dermatology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418302228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418302228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:37:00Z","timestamp":1757597820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418302228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"alternative-id":["S0002939418302228"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.05.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, Controlled, Phase 2 Trial of Povidone-Iodine\/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Shire, Lexington, MA, USA. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}